References
- LjungRPetriniPNilssonIMDiagnostic symptoms of severe and moderate haemophilia A and B. A survey of 140 casesActa Paediatr Scand19907921962002321482
- KasperCKBuzinCHMosaics and haemophiliaHaemophilia20091561181118619473426
- KurachiKDavieEWIsolation and characterization of a cDNA coding for human factor IXProc Natl Acad Sci U S A19827921646164646959130
- GitschierJWoodWIGoralkaTMCharacterization of the human factor VIII geneNature198431259923263306438525
- PalmerTDThompsonARMillerADProduction of human factor IX in animals by genetically modified skin fibroblasts: potential therapy for haemophilia BBlood19897324384452917183
- NathwaniACTuddenhamEGRangarajanSAdenovirus-associated virus vector-mediated gene transfer in haemophilia BN Engl J Med2011365252357236522149959
- NaldiniLBlomerUGallayPIn vivo gene delivery and stable transduction of nondividing cells by a lentiviral vectorScience199627252592632678602510
- NaldiniLBlomerUGageFHTronoDVermaIMEfficient transfer, integration, and sustained long-term expression of the transgene in adult rat brains injected with a lentiviral vectorProc Natl Acad Sci U S A1996932111382113888876144
- BrownBDCantoreAAnnoniAA microRNA-regulated lentiviral vector mediates stable correction of haemophilia B miceBlood2007110134144415217726165
- WardNJBuckleySMWaddingtonSNCodon optimization of human factor VIII cDNAs leads to high-level expressionBlood2011117379880721041718
- CartierNHacein-Bey-AbinaSBartholomaeCCHematopoietic stem cell gene therapy with a lentiviral vector in X-linked adrenoleukodystrophyScience2009326595481882319892975
- Cavazzana-CalvoMPayenENegreOTransfusion independence and HMGA2 activation after gene therapy of human beta-thalassaemiaNature2010467731331832220844535
- ShiQWilcoxDAFahsSALentivirus-mediated platelet-derived factor VIII gene therapy in murine haemophilia AJ Thromb Haemost20075235236117269937
- JohnstonJMDenningGDoeringCBSpencerHTGeneration of an optimized lentiviral vector encoding a high-expression factor VIII transgene for gene therapy of haemophilia AGene Ther201320660761522996197
- DavidoffAMGrayJTNgCYComparison of the ability of adeno-associated viral vectors pseudotyped with serotype 2, 5, and 8 capsid proteins to mediate efficient transduction of the liver in murine and nonhuman primate modelsMol Ther200511687588815922958
- HurlbutGDZieglerRJNietupskiJBPreexisting immunity and low expression in primates highlight translational challenges for liver-directed AAV8-mediated gene therapyMol Ther201018111983199420736932
- VarnavskiANZhangYSchnellMPreexisting immunity to adenovirus in Rhesus monkeys fails to prevent vector-induced toxicityJ Virol200276115711571911991999
- SuzukiMBertinTKRogersGLDifferential type I interferon-dependent transgene silencing of helper-dependent adenoviral vs adeno-associated viral vectors in vivoMol Ther201321479680523319058
- VarnavskiANCalcedoRBoveMGaoGWilsonJMEvaluation of toxicity from high-dose systemic administration of recombinant adenovirus vector in vector-naive and pre-immunized miceGene Ther200512542743615647774
- RaperSEChirmuleNLeeFSFatal systemic inflammatory response syndrome in a ornithine transcarbamylase deficient patient following adenoviral gene transferMol Genet Metab2003801–214815814567964
- RaperSEYudkoffMChirmuleNA pilot study of in vivo liver-directed gene transfer with an adenoviral vector in partial ornithine transcarbamylase deficiencyHum Gene Ther200213116317511779420
- WilsonJMLessons learned from the gene therapy trial for ornithine transcarbamylase deficiencyMol Genet Metab200996415115719211285
- ZaissAKLiuQBowenGPWongNCBartlettJSMuruveDADifferential activation of innate immune responses by adenovirus and adeno-associated virus vectorsJ Virol20027694580459011932423
- RogersGLMartinoATAslanidiGVJayandharanGRSrivastavaAHerzogRWInnate immune responses to AAV vectorsFront Microbiol2011219421954398
- MartinoATSuzukiMMarkusicDMThe genome of self-complementary adeno-associated viral vectors increases Toll-like receptor 9-dependent innate immune responses in the liverBlood2011117246459646821474674
- FaustSMBellPCutlerBJCpG-depleted adeno-associated virus vectors evade immune detectionJ Clin Invest201312372994300123778142
- MartinoATBasner-TschakarjanEMarkusicDMEngineered AAV vector minimizes in vivo targeting of transduced hepatocytes by capsid-specific CD8+ T cellsBlood2013121122224223323325831
- NathwaniACRosalesCMcIntoshJLong-term safety and efficacy following systemic administration of a self-complementary AAV vector encoding human FIX pseudotyped with serotype 5 and 8 capsid proteinsMol Ther201119587688521245849
- CaoODobrzynskiEWangLInduction and role of regulatory CD4+CD25+ T cells in tolerance to the transgene product following hepatic in vivo gene transferBlood200711041132114017438084
- YangYNunesFABerencsiKFurthEEGönczölEWilsonJMCellular immunity to viral antigens limits E1-deleted adenoviruses for gene therapyProc Natl Acad Sci U S A19949110440744118183921
- YangYErtlHCJWilsonJMMHC class I-restricted cytotoxic T lymphocytes to viral antigens destroy hepatocytes in mice infected with E1-deleted recombinant adenovirusesImmunity1994154334427533647
- RothDATawaNEO’BrienJMTrecoDASeldenRFNonviral transfer of the gene encoding coagulation factor VIII in patients with severe haemophilia AN Engl J Med2001344231735174211396439
- PowellJSRagniMVWhiteGCPhase 1 trial of FVIII gene transfer for severe haemophilia A using a retroviral construct administered by peripheral intravenous infusionBlood200310262038204512763932
- WhiteGCMonahanPEGene therapy for haemophilia ALeeCABerntorpEEHootsKTextbook of Haemophilia2nd edHoboken, NJWiley-Blackwell2005
- HerzogRWHagstromJNKungSHStable gene transfer and expression of human blood coagulation factor IX after intramuscular injection of recombinant adeno-associated virusProc Natl Acad Sci U S A19979411580458099159155
- HerzogRWYangEYCoutoLBLong-term correction of canine haemophilia B by gene transfer of blood coagulation factor IX mediated by adeno-associated viral vectorNat Med19995156639883840
- MannoCSChewAJHutchisonSAAV-mediated factor IX gene transfer to skeletal muscle in patients with severe haemophilia BBlood200310182963297212515715
- BuchlisGPodsakoffGMRaduAFactor IX expression in skeletal muscle of a severe haemophilia B patient 10 years after AAV-mediated gene transferBlood2012119133038304122271447
- MannoCSPierceGFArrudaVRSuccessful transduction of liver in haemophilia by AAV-Factor IX and limitations imposed by the host immune responseNat Med200612334234716474400
- ArrudaVRFieldsPAMilnerRLack of germline transmission of vector sequences following systemic administration of recombinant AAV-2 vector in malesMol Ther20014658659211735343
- MingozziFHighKAImmune responses to AAV vectors: overcoming barriers to successful gene therapyBlood20131221233623596044
- MingozziFMausMVHuiDJCD8(+) T-cell responses to adeno-associated virus capsid in humansNat Med200713441942217369837
- LiCGoudyKHirschMCellular immune response to cryptic epitopes during therapeutic gene transferProc Natl Acad Sci U S A200910626107701077419541644
- HalbertCLMetzgerMJLamSLMillerADCapsid-expressing DNA in AAV vectors and its elimination by use of an oversize capsid gene for vector productionGene Ther201118441141721160534
- HauckBMurphySLSmithPHUndetectable transcription of cap in a clinical AAV vector: implications for preformed capsid in immune responsesMol Ther200917114415218941440
- CalcedoRVandenbergheLHGaoGLinJWilsonJMWorldwide epidemiology of neutralizing antibodies to adeno-associated virusesJ Infect Dis2009199338139019133809
- VandenbergheLHWangLSomanathanSHeparin binding directs activation of T cells against adeno-associated virus serotype 2 capsidNat Med200612896797116845388
- NathwaniACGrayJTMcIntoshJSafe and efficient transduction of the liver after peripheral vein infusion of self-complementary AAV vector results in stable therapeutic expression of human FIX in nonhuman primatesBlood200710941414142117090654
- WangZMaHILiJSunLZhangJXiaoXRapid and highly efficient transduction by double-stranded adeno-associated virus vectors in vitro and in vivoGene Ther200310262105211114625564
- McCartyDMMonahanPESamulskiRJSelf-complementary recombinant adeno-associated virus (scAAV) vectors promote efficient transduction independently of DNA synthesisGene Ther20018161248125411509958
- NathwaniACGrayJTNgCYSelf-complementary adeno-associated virus vectors containing a novel liver-specific human factor IX expression cassette enable highly efficient transduction of murine and nonhuman primate liverBlood200610772653266116322469
- AllayJASleepSELongSGood manufacturing practice production of self-complementary serotype 8 adeno-associated viral vector for a haemophilia B clinical trialHum Gene Ther201122559560421410419
- DolanBPBenninkJRYewdellJWTranslating DRiPs: progress in understanding viral and cellular sources of MHC class I peptide ligandsCell Mol Life Sci20116891481148921416150
- MendellJRCampbellKRodino-KlapacLDystrophin immunity in Duchenne’s muscular dystrophyN Engl J Med2010363151429143720925545
- MorganRAYangJCKitanoMDudleyMELaurencotCMRosenbergSACase report of a serious adverse event following the administration of T cells transduced with a chimeric antigen receptor recognizing ERBB2Mol Ther201018484385120179677
- LinetteGPStadtmauerEAMausMVCardiovascular toxicity and titin cross-reactivity of affinity enhanced T cells in myeloma and melanomaBlood2013122686387123770775
- SimioniPTormeneDTogninGX-linked thrombophilia with a mutant factor IX (factor IX Padua)N Engl J Med2009361171671167519846852
- FinnJDNicholsTCSvoronosNThe efficacy and the risk of immunogenicity of FIX Padua (R338L) in haemophilia B dogs treated by AAV muscle gene therapyBlood2012120234521452322919027
- WrightJFManufacturing and characterizing AAV-based vectors for use in clinical studiesGene Ther2008151184084818418418
- PierceGFLillicrapDPipeSWVandendriesscheTGene therapy, bioengineered clotting factors and novel technologies for haemophilia treatmentJ Thromb Haemost20075590190617459005
- BohnRLSchrammWBullingerMvan den BergMBlanchetteVOutcome measures in haemophilia: more than just factor levelsHaemophilia200410Suppl 12814987243
- McIntoshJLentingPJRosalesCTherapeutic levels of FVIII following a single peripheral vein administration of rAAV vector encoding a novel human factor VIII variantBlood2013121173335334423426947
- RamgrenOA clinical and medico-social study of haemophilia in SwedenActa Med Scand Suppl196237911119014490113
- DarbySCKanSWSpoonerRJMortality rates, life expectancy, and causes of death in people with haemophilia A or B in the United Kingdom who were not infected with HIVBlood2007110381582517446349
- LjungRCCan haemophilic arthropathy be prevented?Br J Haematol199810122152199609513
- LofqvistTNilssonIMBerntorpEPetterssonHHaemophilia prophylaxis in young patients – a long-term follow-upJ Intern Med199724153954009183307